KCI Usa, Inc.

KCI USA, Inc., doing business as Solventum Advanced Wound Care, is a subsidiary of 3M Company that manufactures negative pressure wound therapy systems, wound vacuum-assisted closure equipment, and advanced wound care supplies for the federal government. The company operates as a prime contractor on full-and-open competition across all its federal work, with no small business set-asides or socioeconomic designations—reflecting its large for-profit status within the 3M portfolio. Roughly 100 percent of federal awards sit on the prime side, with minimal subcontractor engagement; KCI USA delivers wound care solutions directly to federal customers across the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and NIH Clinical Center.

KCI USA's federal footprint is overwhelmingly concentrated in wound care rental, equipment lease, and supply delivery. The core capability is negative pressure wound therapy (NPWT) systems—proprietary wound vacuum-assisted closure devices marketed as ActiV.A.C., V.A.C. ULTA, and related rentals—sold via delivery orders, blanket purchase agreement calls, and purchase orders under the company's $340 million multiple-award Federal Supply Schedule contract (Medical Equipment and Supplies, FSS-65-II-A) with the Department of Veterans Affairs, awarded in June 2023 through May 31, 2028. Representative work includes a $2.2 million wound care management VAC lease to Veterans Integrated Service Network 21 running through June 2027, a $813 thousand wound VAC and PIMC delivery order to the Indian Health Service through August 2027, a $780 thousand KCI VACULTA therapy maintenance agreement with VISN 8 through September 2027, and recurring wound vacuum rental orders across 15 Veterans Integrated Service Networks with individual ceiling values ranging from $25 thousand to $1.6 million.

Customer concentration sits heavily with the Veterans Integrated Service Networks. The top five customers by dollar value account for 91 percent of combined potential value across all awards, with VISN 12 anchoring the list at $663.6 million in combined potential value across 17 awards—a concentration driven by a single large lease agreement. VISN 22 places second at $15.7 million across 190 awards, followed by VISN 21 ($11.3 million, 102 awards), VISN 9 ($10.5 million, 157 awards), and VISN 5 ($6.7 million, 55 awards). By award count, VISN 15 leads with 337 awards at $3.1 million combined potential value, reflecting the breadth of small, recurring wound VAC rental calls. The Defense Health Agency, Indian Health Service, and NIH Clinical Center round out the customer set, with smaller but strategically important presence in military and federal healthcare procurement. No federal agency outside the healthcare space appears in the top-tier customer list.

KCI USA's vehicle position is tightly anchored to the Medical Equipment and Supplies FSS-65-II-A schedule, which carries 1,850 task orders at $110.6 million in combined potential value—accounting for the vast majority of federal activity. The company holds secondary Federal Supply Schedule contracts (V797P3755J and V797P3608H) and manages single-award blanket purchase agreements across multiple Veterans Integrated Service Networks and with the Defense Health Agency. These BPAs serve as decentralized ordering vehicles beneath the parent FSS contract, with ceiling values ranging from $25 thousand (VISN 15) to $1.58 million (VISN 5 NPWT rental). Across the BPA portfolio, 13 identified agreements carry combined potential values exceeding $8 million and ultimate completion dates extending through 2030.

Activity has remained steady over the past five years—45 awards in 2022, 40 in 2023, 57 in 2024, 47 in 2025, and 12 through early 2026. The source contains 2,184 total awards with combined potential value of $779.7 million, though only $61.7 million (8 percent) has been obligated to date, reflecting the nature of Federal Supply Schedule and BPA vehicles, which carry ceilings but generate modest year-to-year task order flow. Recompete risk is modest: 28 awards with ultimate completion dates in the next twenty-four months carry combined potential value of $11.9 million, concentrated in routine wound VAC rental BPA calls across Veterans Integrated Service Networks.

SCI-reported federal service contract invoicing totaled $1.2 million in FY2024 across 0.3 FTEs, reflecting the company's machinery-of-government data reporting for service contracts above the $150,000 threshold. This figure excludes the bulk of KCI USA's federal revenue, which flows as product sales, rental equipment, and supplies under the Medical Equipment and Supplies FSS schedule and is captured as goods procurement rather than services. On the reported service contracts, government-paid hourly rates ran a median of $1,285 per hour (10th percentile $854, 90th percentile $2,833), with no subcontractor labor engagement. The SCI dataset captures only a narrow slice of the company's federal work; the $779.7 million combined potential value of awards in the broader portfolio dwarfs the $1.2 million SCI invoicing and reflects KCI USA's dominant model of equipment sales, rentals, and maintenance services rather than labor-hour contract work.

KCI USA operates as a self-performing prime across its federal footprint, with zero subcontractor engagement in the award record. The vendor subcontracts minimally to other primes—three documented sub-awards to Cardinal Health 200, LLC for medical and surgical supplies represent occasional flow-through arrangements rather than strategic teaming. The company brings no significant subcontractor ecosystem to teaming arrangements and does not position itself as a feeder to larger government contractors. Federal procurement of KCI USA's wound care solutions runs direct from end-user VA networks and federal health agencies to the manufacturer, leveraging 3M Company's established quality, logistics, and customer service infrastructure.

The vendor is a wholly-owned subsidiary of 3M Company (UEI YLQMY5SGNE55, headquartered St. Paul, Minnesota), operating under the "Government Markets" division and also identified as Solventum Advanced Wound Care in recent contract documents. The parent-subsidiary relationship does not appear to structure federal contracting through a holding company; KCI USA holds its own Federal Supply Schedule contracts and BPA awards under its distinct UEI. The relationship provides access to 3M's manufacturing, materials science, intellectual property, and federal account management capabilities, positioning KCI USA as a proprietary supplier for wound vacuum-assisted closure systems that competitors cannot easily replicate.